MORE►
ZS Pharma
Renibus Therapeutics CEO Jeff Keyser [Composite photo; original: Renibus Therapeutics]
BioNTX To Honor Renibus Therapeutics CEO with its 2024 Dennis K. Stone Award at iC³ Conference
by Lance Murray | Oct 2, 2024
Renibus CEO Jeff Keyser will be acknowledged as the award recipient at the 10th Annual iC³ Life Science & Healthcare Innovation Summit on Thursday, the first day of the Oct. 3-4 summit at the Loews Arlington Hotel & Convention Center.
by Kevin Cummings |
Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE►
by Lauren Hawkins |
Jul 21, 2020
Nanoscope Therapeutics, a TechFW client, has closed an over-subscribed Series A funding round for its leading work on retinas, which could enable the blind to see.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
MORE►
by Jeff Bounds |
Jan 22, 2020
Here are notable organizations that veterans of the eye care giant have started or hold executive positions in.
MORE►
[Illustration: kmlmtz66/iStock]
Master Minds:
North Texas Idea Generators
by Nicholas Sakelaris | Jan 30, 2018
These North Texas innovators are making a name for themselves, in areas from startup to enterprise and creative to education.
MORE►
